Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2006-2-22
pubmed:abstractText
Several novel, fully synthetic, carbohydrate-based antitumor vaccines have been assembled. Each construct consists of multiple cancer-related antigens displayed on a single polypeptide backbone. Recent advances in synthetic methodology have allowed for the incorporation of a complex oligosaccharide terminating in a sialic acid residue (i.e., GM2) as one of the carbohydrate antigens. Details of the vaccine synthesis as well as the results of preliminary immunological investigations are described herein.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0002-7863
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
128
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2715-25
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:16492059-Amino Acids, pubmed-meshheading:16492059-Animals, pubmed-meshheading:16492059-Antigens, Neoplasm, pubmed-meshheading:16492059-Breast Neoplasms, pubmed-meshheading:16492059-Cancer Vaccines, pubmed-meshheading:16492059-Carbohydrate Sequence, pubmed-meshheading:16492059-Cell Line, Tumor, pubmed-meshheading:16492059-Female, pubmed-meshheading:16492059-G(M2) Ganglioside, pubmed-meshheading:16492059-Glycosides, pubmed-meshheading:16492059-Hemocyanin, pubmed-meshheading:16492059-Humans, pubmed-meshheading:16492059-Male, pubmed-meshheading:16492059-Mice, pubmed-meshheading:16492059-Molecular Sequence Data, pubmed-meshheading:16492059-Oligosaccharides, pubmed-meshheading:16492059-Peptides, pubmed-meshheading:16492059-Prostatic Neoplasms, pubmed-meshheading:16492059-Sialic Acids
pubmed:year
2006
pubmed:articleTitle
Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates.
pubmed:affiliation
Laboratory of Tumor Vaccinology, Clinical Immunology Service, Department of Medicine, the Laboratory for Bioorganic Chemistry, Sloan-Kettering Institute for Cancer Research, New York, New York 10021, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural